USA

George L. Drusano, MD
Co-Director
Ordway Research Institute
Albany
New York

George L. Drusano brings considerable experience in all aspects of anti-infective research and development, is distinguished for his knowledge of pharmocodynamics and is expert in FDA interactions. George is a Co-Director at the Ordway Research Institute in Albany, USA.

<< Back

John R. Graybill, MD
Professor of Medicine
Chief of Infectious Diseases
Infectious Diseases Division
Audie Murphy Memorial Veterans Hospital
San Antonio

John R. Graybill, (Dick Graybill) enjoys the reputation as one of the world experts in pre-clinical and clinical anti-fungal drug development and has been associated with all new agents introduced in the last 20 years. Dick is Professor of Medicine at the Audie Murphy Memorial Veterans Hospital in San Antonio, USA.

<< Back

John Perfect, MD
Professor, Department of Medicine, Division of Infectious Diseases
Director, Duke University Mycology Research Unit
Duke University Medical Center
Durham

John Perfect, MD is Professor, Department of Medicine, Division of Infectious Diseases at the Duke University Medical Centre, New Carolina, USA. John combines his academic duties with lead roles in clinical trialling of new anti-fungal agents. His services are sought by all major antifungal companies.

<< Back

David Denning, MB, FRCP, FRCPath
Education and Research Centre
Wythenshawe Hospital
Manchester

David Denning is Professor of Medicine and Medical Mycology in the University of Manchester UK. David is a practising clinician and a founder of F2G. He maintains an active research program in many areas of antifungal therapy, genomics of Aspergillus and antifungal resistance and has significant experience in both the pre-clinical and clinical evaluations of novel agents.

<< Back

Bart Jan Kullberg, M.D.
Professor of Medicine, Radboud University Nijmegen
Chair, Nijmegen University Center for Infectious Diseases (NUCI);
Chief, Infectious Diseases Section
Department of Medicine (541)
Radboud University Medical Center
Nijmegen
The Netherlands;

Bart Jan Kullberg holds several academic positions, including Professor of Medicine, in Nijmegen, The Netherlands. He is an experienced clinical trialist having worked on all or most of the recently introduced anti-fungal agents. He currently serves on the ICAAC programme committee reviewing anti-fungal studies.

<< Back